The MarketWatch News Department was not involved in the creation of this content. Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use ...

At 8 months follow-up, patients with painful diabetic peripheral neuropathy who received spinal cord stimulation (SCS) implants reported improvements in pain, neuropathic and autonomic symptoms, ...

Spinal cord stimulation (SCS) to treat pain in persons with multiple sclerosis (MS) was the focus of a recent literature review out of Italy. An analysis from Italy of 7 studies that investigated ...

Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use and lower explant rates LAKE OSWEGO, Ore., Jan. 5, 2026 /PRNewswire/ -- A new ...

The Evoke ® System is the First SCS System to Demonstrate Cost-Dominance at Two Years Post-Implant MINNEAPOLIS, Aug. 4, 2023 /PRNewswire/ -- Saluda Medical, Inc. ("Saluda Medical"), a global medical ...

The new implant is essentially a type of advanced spinal cord stimulator, which are devices that sit in between the spinal cord and the vertebrate and emit electrical pulses that disrupt pain signals.